COMMUNIQUÉS West-GlobeNewswire

Sorrento Therapeutics to Present at the 28th Annual Oppenheimer Conference (NY) on 03/20/18
15/03/2018
SAN DIEGO, March 14, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) ("Sorrento"), announced today that it will present at the Oppenheimer 28 th annual conference on 03/20/18 at 2:45 PM EST (Westin [...]
Genesis to Present at the Barclays Global Healthcare Conference on March 15, 2018; Expects to Release Fourth Quarter and Year End 2017 Results on March 16, 2018
15/03/2018
KENNETT SQUARE, Pa., March 14, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE: GEN ) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that George V. Hager, Jr., [...]
Telix Pharmaceuticals and Radboud University Medical Centre Conclude Clinical Collaboration Agreement
15/03/2018
MELBOURNE, Australia and NIJMEGAN, The Netherlands, March 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the [...]
Proteostasis Therapeutics Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Business Update
14/03/2018
14-day Study of PTI-801, Company’s Third Generation Corrector, in CF Patients on Background Orkambi ® Enrolling Ahead of Schedule; Results from All Three Cohorts Expected Q2'18 Company Announces Additional Study of PTI- [...]
Leap Therapeutics Provides DKN-01 Program Update and Announces Scientific Presentations at AACR Annual Meeting
14/03/2018
CAMBRIDGE, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ: LPTX ), a biotechnology company developing targeted and immuno-oncology therapeutics, today presented promising clinical data from [...]
NewLink Genetics Announces Presentation of Abstracts at AACR Annual Meeting
14/03/2018
AMES, Iowa, March 14, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) today reported that two abstracts pertaining to the company's indoximod program will be presented at the American Association [...]
TESARO Announces Data Presentations at the 2018 American Association for Cancer Research Annual Meeting
14/03/2018
WALTHAM, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO ), an oncology-focused biopharmaceutical company, today announced that data for ZEJULA, TSR-042 (anti-PD-1 antibody) and the company’s immuno [...]
Solid Biosciences Announces Clinical Hold On SGT-001 Phase I/II Clinical Trial For Duchenne Muscular Dystrophy
14/03/2018
CAMBRIDGE, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ: SLDB ) today announced it has received notification from the U.S. Food and Drug Administration (FDA) that IGNITE DMD, its Phase I/II [...]
Aduro Biotech Announces Upcoming Data Presentations at the 2018 American Association for Cancer Research Annual Meeting
14/03/2018
BERKELEY, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq: ADRO ), today announced three preclinical data presentations highlighting its STING and antibody product candidates will be delivered at [...]
Proteostasis Therapeutics Announces FDA Grants Orphan Drug Designation for PTI-428 in Cystic Fibrosis
14/03/2018
CAMBRIDGE, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI ), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to [...]
The Ensign Group to Present at the Oppenheimer 28th Annual Healthcare Conference
14/03/2018
MISSION VIEJO, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG ), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health, home care, hospice [...]
Precision Therapeutics Increases Equity Stake in Helomics to 25%
14/03/2018
MINNEAPOLIS, March 14, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), formerly Skyline Medical, a company focused on applying artificial intelligence to personalized [...]
Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2017 Financial Results and Provides Corporate Update
14/03/2018
--Firdapse ® NDA to be Resubmitted Before the End of this Quarter --Significant Progress with MuSK-MG Regulatory and Clinical Program --$84M Year-End Cash and Investments --Company to Host Quarterly Conference Call at 5 [...]
Novavax Provides Corporate Update and Report of Fourth Quarter and Year-End 2017 Financial Results
14/03/2018
RSV Phase 3 Prepare™ Trial Outcome De-risked by Successful Informational Analysis NanoFlu™ Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine John J. Trizzino Appointed Chief [...]
Inovio Pharmaceuticals Reports 2017 Fourth Quarter and Year End Financial Results
14/03/2018
PLYMOUTH MEETING, Pa., March 14, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today reported financial results for the fourth quarter and year ended December 31, 2017. Total revenue was $8.8 [...]
Novavax Promotes John J. Trizzino to Expanded Role as Chief Business Officer and Chief Financial Officer
14/03/2018
GAITHERSBURG, Md., March 14, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq: NVAX ) today announced the promotion of John J. Trizzino to Senior Vice President, Chief Business Officer (CBO) and Chief Financial Officer ( [...]
miRagen Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
14/03/2018
Data from Phase 1 clinical trial supports advancing cobomarsen, or MRG-106, into a Phase 2 potentially registrational clinical trial for CTCL (the SOLAR trial) Completed Phase 1 clinical trial of MRG-201 supports [...]
Sunesis Pharmaceuticals to Present at Upcoming Investor Conferences
14/03/2018
SOUTH SAN FRANCISCO, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced that the Company will present at two upcoming investor conferences. Willie Quinn, Chief [...]
Carrie Arran Resources Announces Proposed Private Placement With Insider Participation
14/03/2018
TORONTO, March 14, 2018 (GLOBE NEWSWIRE) -- Carrie Arran Resources Inc. (the “ Corporation ”) is pleased to announce a proposed non-brokered private placement (the “ Private Placement ”) of up to 600,000 common shares [...]

Pages